Two new simple, accurate and precise UV-VIS spectrophotometric methods have been developed for simultaneous estimation of Terbinafine and Itraconazole in bulk and pharmaceutical dosage forms. The first method is simultaneous estimation using vierodt's equation where absorption maxima found at 289nm and 282nm for Terbinafine (TER) and Itraconazole (ITZ) respectively. The second method is based on Qmethod / Absorption ratio method using two wavelengths, at 285nm (Isobestic point) and 289nm(λmax for Terbinafine). Two methods follow Beer's linearity in the range of 10-35µg/ml for Terbinafine and 5-30µg/ml for Itraconazole with correlation coefficient r 2 of 0.999 and 0.999
INTRODUCTION
Terbinafine hydrochloride is a synthetic allylamine antifungal. It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues. Chemically Terbinafine is N-(6, 6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethanamine. It is used for the treatment of dermatophyte infections of the toenail or fingernail caused by susceptible fungi. Also for the treatment of tinea capitis (scalp ringworm) and tinea corporis (body ringworm) or tinea cruris (jock itch). (1, 2) Itraconazole is the triazole antifungal agents that inhibit cytochrome P-450-dependent enzymes resulting in impairment of ergosterol synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis & aspergillosis. Chemically Itraconazole is1-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5 dihydro-1H-1,2,4-triazol-5-one 705.64 g/mol. It is used for the treatment of the following fungal infections in immune compromised and nonimmuno compromised patients: pulmonary and extra pulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis. (3, 4) Various analytical methods reported for determination of Terbinafine and Itraconazole using UV Spectroscopy, HPLC and other chromatographic methods in plasma and pharmaceutical formulation. However, there are no reported methods for simultaneous estimation of both drugs in combined pharmaceutical formulation. This paper presents two simple, rapid, accurate, precise methods for the simultaneous analysis estimation of both the drugs in bulk and from pharmaceutical dosage form.
MATERIALS AND METHODS

Instruments
IR Spectrophotometer (Jasco460 plus Spectrophotometer), UV-Vis Spectrophotometer (Jasco V530Spectrophotometer) in R.D.'s College of Pharmacy, Bhor (Pune).
Materials
Standard gift samples of Terbinafine and Itraconazole were procured from (Sankalp Healthcare and Allied Products, Karad). Tablet formulation containing both drugs (Terbiface Plus) purchased from local market.
Preparation of Stock Solutions
10mg of Terbinafine and 10mg of Itraconazole were weighed accurately and transferred to a separate 10ml volumetric flask, dissolved in sufficient quantity of dichloro methane then sonicated for 15 min and diluted to 10ml with the same solvent so as to get the concentration of 1000 μg/ml.
Determination of Λmax
The standard solutions of Terbinafine (25μg/ml) and Itraconazole (10μg/ml) were scanned separately in the wavelength range of 200 -400 nm and the λ max was found to be 289 nm and 282nm respectively. Overlain spectra shows absorption maxima at 285nm. For simultaneous equation method, 289nm and 282nm were selected for analysis. For Q-method 289nm and 285nm were selected for analysis. UV spectra of Terbinafine, Itraconazole and overlain spectra of both drugs are shown in fig. 1 .1, 1.2, 1.3. 
Method A: Simultaneous Equation Method
If a sample contains two absorbing drug each of which absorbs at the λ max of the other, it may be possible to determine both drugs by the technique of simultaneous equation. Two wavelengths selected for the development of the simultaneous equations are 289 nm and 282 nm. The absorptivity values determined for Terbinafine at 289 and 282 are (ax1), and (ax2), and for Itraconazole are (ay1), and (ay2) at 289 nm and 282 nm respectively. The absorbance and absorptivity at these wavelengths were substituted in equation 1 and 2 to obtain the concentration of both drugs. 
Method B: Absorbance Ratio Method/ Q-Analysis
Absorbance ratio method of analysis is based on the absorbance at two selected wavelengths, one of which is an Isoabsorptive point and the other being the wavelength of maximum absorption of one drug. From overlain spectra of Terbinafine and Itraconazole 285 nm and 289 nm are selected for the formation of Q absorbance equation. The absorptivity values determined for Terbinafine at 289 nm are (ax1), and 285 nm are (ax2) and for Itraconazole at 289 nm are (ay1), at 285 nm are (ay2). The absorbance and absorptivity at these wavelengths were substituted in equation 3 and 4 to obtain the concentration of drugs.
Where, A1 and A2 are absorbance of mixture at 289 and 285 nm respectively, ax1 and ay1 are absorptivity of Terbinafine and Itraconazole at 237.5nm respectively, ax2 and ay2 are absorptivity of Terbinafine and Itraconazole at 258 nm respectively, QM=A2/A1, QX=ax2/ax1 and QY=ay2/ay1
Validation of UV-Visible Spectrophotometric Methods Linearity and Range
From the standard stock solution of Terbinafine, appropriate aliquots were pipette out into 10 ml volumetric flasks and dilutions were made with dichloro methane to obtain working standard solutions of concentrations 10, 15, 20, 25, 30, 35 μg/ml. Similarly from the standard stock solution of Itraconazole subsequent dilution were made with dichloro methane to obtain working standard solution of concentration 5, 10, 15, 20, 25, 30, μg/ml. For simultaneous equation method solutions were scanned at 289nm and 285nm for Terbinafine and Itraconazole. The calibration curve of the drugs was plotted. For Q-Absorption ratio method solution were scanned at 285nm (isoabsorptive point) and 289nm (λmax of Terbinafine). The calibration curves were plotted. Linear regression equation of Terbinafine and Itraconazole at all wavelength were determined.
Accuracy and Recovery Studies
To check the accuracy of the proposed method, recovery studies were carried out by standard addition method at three different levels according to ICH guidelines. A series of solutions of Terbinafine and Itraconazole at 80%, 100%, and 120% of the standard preparation in the ratio of the formulation were prepared and checked for accuracy by determining the absorbance values at 289nm and 282nm (Method A) ,285nm and 289nm (Method B). To a fixed concentration of the formulation, varying concentrations of pure drug solutions were added and percentage recoveries calculated. Precision Precision of method was studied as intra-day precision and interday precision variation. Intra-day precision was determined by analysing 20, 25 and 30μg/ml of Terbinafine and 5, 10,15 μg/ml of Itraconazole solution for three times in the same day. Inter-day precision was determined by analysing 20, 25 and 30μg/ml of Terbinafine and 5, 10,15 μg/ml of Itraconazole solutions daily for three days in the week. In both intra and inter-day precision study for the methods %RSD were calculated.
Limit of Detection and Limit of Quantitation
The limit of detection and limit of quantification of Terbinafine and Itraconazole by proposed methods were determined using calibration standards. LOD and LOQ were calculated as 3.3σ/S and 10σ/S, respectively, where S is the slope of the calibration curve and σ is the standard deviation of response.
Ruggedness
The ruggedness of the proposed method was determine for 25μg/ml concentration of Terbinafine and 10 μg/ml concentration of Itraconazole by analysis of aliquots from a homogenous slot by two analyst using same operational and environmental conditions .The result was indicated as% RSD.
Robustness
The robustness of the method was determined by introducing small changes in UV parameters, such as changing in the wavelength ± 5. 
RESULTS AND DISCUSSION
Linearity and Range
Precision:
The precision of the method was expressed in terms of % relative standard deviation (%RSD).
The %RSD values found to be less than 2 for intra-day and inter-day precision, which indicate that the proposed method is precise for analysis. The result is expressed in 
.LOD AND LOQ
The LOD and LOQ for Terbinafine and Itraconazole were found in μg/ml and the result is expressed in 
Robustness
The robustness of the method was determined by introducing small changes in UV parameters, such as changing in the wavelength ± 5.The result was indicated as % RSD. The result expressed in formulations. The developed methods were validated and from the statistical data, it was found that the methods were linear, accurate and precise and can be successfully applied for the analysis of pharmaceutical formulations without interference of excipients.
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